Showing results (261-270 of 289) with videos related to
Sort By:
Pageof 29
Oncology|December 31, 2025
High Pathological Response and Favorable Survival after Presurgical Sequential Lenvatinib - Transarterial Chemoembolization for Resectable Hepatocellular carcinomaHideki Sasanuma, Yoshiyuki Meguro, Kentaro Shimodaira, et al.Molecular Therapy. Methods & Clinical Development|September 11, 2023
Efficient gene transduction in pigs and macaques with the engineered AAV vector AAV.GT5 for hemophilia B gene therapyYuji Kashiwakura, Kazuhiro Endo, Atsushi Ugajin, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2011
Identification of adipophilin as a potential plasma biomarker for colorectal cancer using label-free quantitative mass spectrometry and protein microarrayJunichi Matsubara, Kazufumi Honda, Masaya Ono, et al.Surgical Oncology|February 21, 2026
Real-world oncological and pathological outcomes after neoadjuvant chemotherapy with gemcitabine plus S-1 for resectable pancreatic cancer: A propensity score-matched cohort studyMasanobu Taguchi, Hideki Sasanuma, Kentaro Shimodaira, et al.Surgery|July 12, 2022
Risk factors associated with hypoglycemic events after total pancreatectomy: A nationwide multicenter prospective study in JapanHironobu Suto, Keiko Kamei, Hiroyuki Kato, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 31, 2020
NLRP3 Inflammasome Activation in Lung Vascular Endothelial Cells Contributes to Intestinal Ischemia/Reperfusion-Induced Acute Lung InjuryHomare Ito, Hiroaki Kimura, Tadayoshi Karasawa, et al.Plos One|October 12, 2012
Altered plasma apolipoprotein modifications in patients with pancreatic cancer: protein characterization and multi-institutional validationKazufumi Honda, Takuji Okusaka, Klaus Felix, et al.Lancet (London, England)|June 7, 2016
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)Katsuhiko Uesaka, Narikazu Boku, Akira Fukutomi, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 15, 2010
Reduced plasma level of CXC chemokine ligand 7 in patients with pancreatic cancerJunichi Matsubara, Kazufumi Honda, Masaya Ono, et al.Nature Communications|March 13, 2024
Inhibition of 7-dehydrocholesterol reductase prevents hepatic ferroptosis under an active state of sterol synthesisNaoya Yamada, Tadayoshi Karasawa, Junya Ito, et al.Pageof 29